657 related articles for article (PubMed ID: 34499599)
1. Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy.
Baj A; Novazzi F; Pasciuta R; Genoni A; Ferrante FD; Valli M; Partenope M; Tripiciano R; Ciserchia A; Catanoso G; Focosi D; Maggi F
Emerg Infect Dis; 2021 Dec; 27(12):3180-3182. PubMed ID: 34499599
[TBL] [Abstract][Full Text] [Related]
2. A CLUSTER OF SARS-COV-2 DELTA VARIANT OF CONCERN ADDITIONALLY HARBORING F490S, NORTHERN LOMBARDY, ITALY.
Novazzi F; Baj A; Pasciuta R; Genoni A; Drago Ferrante F; Tripiciano R; Catanoso G; Focosi D; Maggi F
Int J Infect Dis; 2022 Mar; 116():271-272. PubMed ID: 34995777
[TBL] [Abstract][Full Text] [Related]
3. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
Nonaka CKV; Franco MM; Gräf T; de Lorenzo Barcia CA; de Ávila Mendonça RN; de Sousa KAF; Neiva LMC; Fosenca V; Mendes AVA; de Aguiar RS; Giovanetti M; de Freitas Souza BS
Emerg Infect Dis; 2021 May; 27(5):1522-1524. PubMed ID: 33605869
[TBL] [Abstract][Full Text] [Related]
4. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
[TBL] [Abstract][Full Text] [Related]
5. Genomic Sequencing of SARS-CoV-2 E484K Variant B.1.243.1, Arizona, USA.
Skidmore PT; Kaelin EA; Holland LA; Maqsood R; Wu LI; Mellor NJ; Blain JM; Harris V; LaBaer J; Murugan V; Lim ES
Emerg Infect Dis; 2021 Oct; 27(10):2718-2720. PubMed ID: 34545803
[TBL] [Abstract][Full Text] [Related]
6. Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021.
Trobajo-Sanmartín C; Miqueleiz A; Portillo ME; Fernández-Huerta M; Navascués A; Sola Sara P; López Moreno P; Ordoñez GR; Castilla J; Ezpeleta C
J Clin Microbiol; 2021 Nov; 59(12):e0173621. PubMed ID: 34495709
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021.
Shobayo B; Mishra M; Sameroff S; Petrosov A; Ng J; Gokden A; MaCauley J; Jain K; Renken C; Duworko JT; Badio M; Jallah W; Hensley L; Briese T; Lipkin WI; Mishra N
Emerg Infect Dis; 2021 Dec; 27(12):3185-3188. PubMed ID: 34708683
[TBL] [Abstract][Full Text] [Related]
8. Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy.
Maggi F; Novazzi F; Genoni A; Baj A; Spezia PG; Focosi D; Zago C; Colombo A; Cassani G; Pasciuta R; Tamborini A; Rossi A; Prestia M; Capuano R; Azzi L; Donadini A; Catanoso G; Grossi PA; Maffioli L; Bonelli G
Emerg Infect Dis; 2021 Apr; 27(4):1249-1251. PubMed ID: 33567246
[TBL] [Abstract][Full Text] [Related]
9. Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021.
Lassaunière R; Polacek C; Fonager J; Bennedbæk M; Boding L; Rasmussen M; Fomsgaard A
Euro Surveill; 2021 Dec; 26(49):. PubMed ID: 34886943
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Delta Variant among Asiatic Lions, India.
Mishra A; Kumar N; Bhatia S; Aasdev A; Kanniappan S; Sekhar AT; Gopinadhan A; Silambarasan R; Sreekumar C; Dubey CK; Tripathi M; Raut AA; Singh VP
Emerg Infect Dis; 2021 Oct; 27(10):2723-2725. PubMed ID: 34545805
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021.
Glatman-Freedman A; Hershkovitz Y; Kaufman Z; Dichtiar R; Keinan-Boker L; Bromberg M
Emerg Infect Dis; 2021 Nov; 27(11):2919-2922. PubMed ID: 34570694
[TBL] [Abstract][Full Text] [Related]
12. Emergence of SARS-CoV-2 Delta Variant, Benin, May-July 2021.
Yadouleton A; Sander AL; Adewumi P; de Oliveira Filho EF; Tchibozo C; Hounkanrin G; René KK; Ange D; Kohoun RK; Nari RC; Salifou S; Saizonou R; Kakai CG; Bedié SV; Al Onifade F; Nagel M; Aïssi MAJ; Akogbeto P; Drosten C; Wulf B; Moreira-Soto A; Djingarey MH; Hounkpatin B; Drexler JF
Emerg Infect Dis; 2022 Jan; 28(1):205-209. PubMed ID: 34807815
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants.
Kislaya I; Rodrigues EF; Borges V; Gomes JP; Sousa C; Almeida JP; Peralta-Santos A; Nunes B;
Emerg Infect Dis; 2022 Feb; 28(2):331-337. PubMed ID: 34876242
[TBL] [Abstract][Full Text] [Related]
14. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module.
Lee HK; Knabl L; Knabl L; Wieser M; Mur A; Zabernigg A; Schumacher J; Kapferer S; Kaiser N; Furth PA; Hennighausen L
Sci Rep; 2022 Feb; 12(1):2784. PubMed ID: 35181735
[TBL] [Abstract][Full Text] [Related]
15. Emergence of the E484K Mutation in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Lineage B.1.1.345 in Upstate New York.
Lesho E; Corey B; Lebreton F; Ong AC; Swierczewski BE; Bennett JW; Walsh EE; McGann P
Clin Infect Dis; 2022 Mar; 74(5):909-912. PubMed ID: 34086878
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster.
Landsberg HE; Turcinovic J; Sullivan M; Connor JH; Hamer DH; Platt JT
Int J Infect Dis; 2022 Jan; 114():62-64. PubMed ID: 34757200
[TBL] [Abstract][Full Text] [Related]
17. The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy.
Lo Menzo S; Marinello S; Biasin M; Terregino C; Franchin E; Crisanti A; Cattelan A
Infection; 2021 Dec; 49(6):1341-1345. PubMed ID: 33840038
[TBL] [Abstract][Full Text] [Related]
18. Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.
Widera M; Wilhelm A; Hoehl S; Pallas C; Kohmer N; Wolf T; Rabenau HF; Corman VM; Drosten C; Vehreschild MJGT; Goetsch U; Gottschalk R; Ciesek S
J Infect Dis; 2021 Oct; 224(7):1109-1114. PubMed ID: 34223909
[TBL] [Abstract][Full Text] [Related]
19. Possible Human-to-Dog Transmission of SARS-CoV-2, Italy, 2020.
Decaro N; Vaccari G; Lorusso A; Lorusso E; De Sabato L; Patterson EI; Di Bartolo I; Hughes GL; Teodori L; Desario C; Colitti B; Ricci D; Buonavoglia D; Rosati S; Martella V; Cammà C; Agrimi U; Elia G
Emerg Infect Dis; 2021; 27(7):1981-1984. PubMed ID: 33979566
[TBL] [Abstract][Full Text] [Related]
20. Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy.
Baj A; Novazzi F; Drago Ferrante F; Genoni A; Tettamanzi E; Catanoso G; Dalla Gasperina D; Dentali F; Focosi D; Maggi F
Emerg Microbes Infect; 2021 Dec; 10(1):2010-2015. PubMed ID: 34651569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
